439 related articles for article (PubMed ID: 29913554)
21. Selected Phytochemicals and Culinary Plant Extracts Inhibit Fructose Uptake in Caco-2 Cells.
Lee Y; Lim Y; Kwon O
Molecules; 2015 Sep; 20(9):17393-404. PubMed ID: 26393568
[TBL] [Abstract][Full Text] [Related]
22. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
[TBL] [Abstract][Full Text] [Related]
23. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice.
Gouyon F; Caillaud L; Carriere V; Klein C; Dalet V; Citadelle D; Kellett GL; Thorens B; Leturque A; Brot-Laroche E
J Physiol; 2003 Nov; 552(Pt 3):823-32. PubMed ID: 12937289
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the rabbit intestinal fructose transporter (GLUT5).
Miyamoto K; Tatsumi S; Morimoto A; Minami H; Yamamoto H; Sone K; Taketani Y; Nakabou Y; Oka T; Takeda E
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):877-83. PubMed ID: 7980458
[TBL] [Abstract][Full Text] [Related]
25. Sugar sensing by enterocytes combines polarity, membrane bound detectors and sugar metabolism.
Le Gall M; Tobin V; Stolarczyk E; Dalet V; Leturque A; Brot-Laroche E
J Cell Physiol; 2007 Dec; 213(3):834-43. PubMed ID: 17786952
[TBL] [Abstract][Full Text] [Related]
26. Positive regulatory control loop between gut leptin and intestinal GLUT2/GLUT5 transporters links to hepatic metabolic functions in rodents.
Sakar Y; Nazaret C; Lettéron P; Ait Omar A; Avenati M; Viollet B; Ducroc R; Bado A
PLoS One; 2009 Nov; 4(11):e7935. PubMed ID: 19956534
[TBL] [Abstract][Full Text] [Related]
27. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
[TBL] [Abstract][Full Text] [Related]
28. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R
BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000
[TBL] [Abstract][Full Text] [Related]
29. Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle.
Stuart CA; Yin D; Howell ME; Dykes RJ; Laffan JJ; Ferrando AA
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1067-73. PubMed ID: 16803853
[TBL] [Abstract][Full Text] [Related]
30. Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain.
Nualart F; Godoy A; Reinicke K
Brain Res; 1999 Apr; 824(1):97-104. PubMed ID: 10095047
[TBL] [Abstract][Full Text] [Related]
31. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption.
Mahraoui L; Rodolosse A; Barbat A; Dussaulx E; Zweibaum A; Rousset M; Brot-Laroche E
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):629-33. PubMed ID: 8141777
[TBL] [Abstract][Full Text] [Related]
32. Analysis of glucose metabolism by
Han X; Ren H; Nandi A; Fan X; Koehler RC
Sci Rep; 2021 May; 11(1):10885. PubMed ID: 34035344
[TBL] [Abstract][Full Text] [Related]
33. Regulation of rat intestinal GLUT2 mRNA abundance by luminal and systemic factors.
Cui XL; Jiang L; Ferraris RP
Biochim Biophys Acta; 2003 Jun; 1612(2):178-85. PubMed ID: 12787936
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.
Brown RS; Wahl RL
Cancer; 1993 Nov; 72(10):2979-85. PubMed ID: 8221565
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanism underlying the detection of colorectal cancer by 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography.
Izuishi K; Yamamoto Y; Sano T; Takebayashi R; Nishiyama Y; Mori H; Masaki T; Morishita A; Suzuki Y
J Gastrointest Surg; 2012 Feb; 16(2):394-400. PubMed ID: 22065316
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5.
Chan KK; Chan JY; Chung KK; Fung KP
J Cell Biochem; 2004 Dec; 93(6):1134-42. PubMed ID: 15449313
[TBL] [Abstract][Full Text] [Related]
38. Regulation of GLUT5, GLUT2 and intestinal brush-border fructose absorption by the extracellular signal-regulated kinase, p38 mitogen-activated kinase and phosphatidylinositol 3-kinase intracellular signalling pathways: implications for adaptation to diabetes.
Helliwell PA; Richardson M; Affleck J; Kellett GL
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):163-9. PubMed ID: 10926840
[TBL] [Abstract][Full Text] [Related]
39. Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose Transporters.
Ebert K; Ludwig M; Geillinger KE; Schoberth GC; Essenwanger J; Stolz J; Daniel H; Witt H
J Membr Biol; 2017 Apr; 250(2):171-182. PubMed ID: 28083649
[TBL] [Abstract][Full Text] [Related]
40. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
